Sep 2 2009
Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that Children's Hospital & Research Center Oakland has completed its system-wide conversions to Masimo Rainbow SET Pulse CO-Oximetry technology. Standardizing to Masimo Rainbow SET makes Children's Hospital Oakland the first children's hospital to pioneer new continuous noninvasive blood monitoring capabilities hospital-wide--allowing earlier and better clinical decisions without the intermittent pain and wait associated with drawing blood.
By converting to Masimo Rainbow SET, Children's Hospital Oakland clinicians will gain all the benefits and Measure-Through Motion capabilities of Masimo SET pulse oximetry, along with the breakthrough innovation of the first-ever continuous and noninvasive hemoglobin monitoring (SpHb(TM)) technology. Noninvasive hemoglobin will allow clinicians at Children's to detect and treat chronic or acute anemia earlier, identify internal bleeding sooner, and more effectively manage blood transfusions for their patients. The ability to immediately detect and treat potentially life-threatening conditions earlier may help save lives and improve patient outcomes.
Katie Sabato, MS, RRT, director of Respiratory Care, Pulmonary Function & Sleep Labs at Children's Hospital Oakland, stated, "All of our efforts are focused on helping kids get better, which requires a very special level of care and some of the world's most sophisticated technology. Masimo Rainbow SET will allow us to measure critical components of a child's blood quickly and easily, without the pain of a needle stick and the discomfort of having blood drawn. It's also a great example of how we leverage advanced technology and innovative care solutions to improve comfort and care and speed-up a child's recovery."
Masimo Founder and CEO, Joe E. Kiani, stated, "We are proud of our relationship with Children's Hospital Oakland. Children's was one of the first children's hospitals to convert to Masimo SET years ago and, with a history of leadership in the practice of neonatal and pediatric care, they are continuing to lead new efforts to transform pediatric patient care with their conversion to Masimo Rainbow SET Pulse CO-Oximetry. We are delighted that they have chosen to significantly impact the care and treatment of children and advance the practice of medicine using our noninvasive and continuous Rainbow platform."
Masimo Rainbow SpHb is transforming the way patients are managed in the operating room, intensive care unit and emergency department, where clinicians are reporting earlier identification of necessary blood transfusions, reduction in unnecessary transfusions and invasive tests, increased patient safety, and improved clinical outcomes.
Amit Gupta, M.D., pediatric anesthesiologist at Children's Hospital & Research Center Oakland, stated, "Preserving safe hemoglobin levels are always a particular concern for pediatric patients who already have very little hemoglobin to spare. With Masimo Rainbow SET in the peri-operative setting we can noninvasively detect internal bleeding, fluid responsiveness, oxygen saturation, pulse rate, and perfusion--all in a matter of seconds. Having this level of physiological detail immediately available at our fingertips is a tremendous benefit that helps to speed patient assessment, treatment, care, and the safe return to optimal health."
http://www.masimo.com